Xintong Dai
Impact in
- Dermatology top 10%
- Skin Protection and Aging
-
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 3
- RNA Research and Splicing 2
- Oncology 4
- Co-authors
- Huijuan Liu (6 shared papers)Jingxia Han (5 shared papers)Kai Yang (3 shared papers)Tao Sun (4 shared papers)Yuyan Yang (3 shared papers)Hongqi Wang (3 shared papers)Zhiyuan Zhang (2 shared papers)Jing Jin (1 shared paper)
- Journals
- Genes & Diseases (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Advanced Science (1 paper)Frontiers in Oncology (1 paper)Journal of Nanobiotechnology (1 paper)
- Partner nations
- ChinaSwitzerlandBelgium
In The Last Decade
Xintong Dai
13 papers receiving 227 citations
Peers
Comparison fields: 5 of 77
- Dermatology 30
- Cancer Research 30
- Molecular Biology 112
- Cell Biology 26
- Pharmaceutical Science 9
Countries citing papers authored by Xintong Dai
This map shows the geographic impact of Xintong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xintong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xintong Dai more than expected).
Fields of papers citing papers by Xintong Dai
This network shows the impact of papers produced by Xintong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xintong Dai. The network helps show where Xintong Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xintong Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 78 | |
| 2 | 2020 | 47 | |
| 3 | 2021 | 29 | |
| 4 | 2021 | 17 | |
| 5 | 2024 | 14 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 9 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2015 | 2 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Xintong Dai
Xintong Dai is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 16 papers that have together received 230 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), RNA Research and Splicing (2 papers), Phagocytosis and Immune Regulation (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Capital Investment and Risk Analysis (1 paper), Risk and Safety Analysis (1 paper) and Multi-Criteria Decision Making (1 paper). The work is most often cited by research in Dermatology (30 citations), Cancer Research (30 citations), Molecular Biology (112 citations), Cell Biology (26 citations) and Pharmaceutical Science (9 citations). Xintong Dai has collaborated with scholars based in China, Switzerland and Belgium. Frequent co-authors include Huijuan Liu, Jingxia Han, Kai Yang, Tao Sun, Yuyan Yang, Hongqi Wang, Zhiyuan Zhang, Jing Jin, Heng Zhang and Haohao Zhang. Their work appears in journals such as Genes & Diseases, Journal of Experimental & Clinical Cancer Research, Advanced Science, Frontiers in Oncology and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.